Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 To 2021)

Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 To 2021)

ID: 4977 | Pages: 185 | November 2017 | Region: Global


Extracorporeal Membrane Oxygenation Machine Market Size is anticipated to grow at a 4.3% CAGR from 2016 to 2021 and it is estimated that the global market was valued at USD 247.2 million in 2016 and is expected to reach USD 305.12 million by 2021.Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal technique that provides prolonged cardiac and respiratory support to patients whose heart and lungs are inept to provide an adequate amount of gas exchange to sustain life. The technology for ECMO is largely a consequence of cardiopulmonary bypass, which provides shorter-term support. This intervention has mostly been used on children, but it is expecting to see more use in adults with cardiac and respiratory failure. ECMO works by removing blood from the person's body and artificially removing the carbon dioxide and oxygenating red blood cells. Usually, it is used in either post-cardiopulmonary bypass or in late stage treatment of a person with a profound heart and/or lung failure.

The growth of the market can be attributed to the increase in cases of cardiovascular and respiratory diseases, the rise in the adoption of ECMO as a bridge to lung transplantation, rising number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the rise in the geriatric population and the number of people suffering from diseases in populous countries are factors that are expected to drive the market growth. Moreover, increase in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are anticipated to further expand the COPD incidence rate. Identified risk factors, such as the rise in the tobacco consumption trend in both, males and females, are further aiding the market growth. However, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

The global Extracorporeal Membrane Oxygenation Machine Market Segmentation by Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The large share of this segment is primarily due to the high incidences of respiratory failure, rise in lung transplants, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment. The large share of this segment can be credited to factors such as rise in the incidence of respiratory failure, lung cancer, and lung transplants, and increasing adoption of ECMO.

On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Middle East and Africa. North America accounts for the largest share of the market. The Asia-Pacific market is expected to grow at the highest CAGR and aid the revenue pocket for companies offering ECMO systems.

Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Modality                      

                                5.1.1 Introduction           

                                5.1.2 Venovenous ECMO             

                                5.1.3 Venoarterial ECMO             

                                5.1.4 Arteriovenous ECMO         

                                5.1.5  Y-o-Y Growth Analysis, By Modality            

                                5.1.6  Market Attractiveness Analysis, By Modality          

                                5.1.7  Market Share Analysis, By Modality            

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Respiratory Applications   

                                                5.2.2.1 Neonates

                                                5.2.2.2 Pediatrics

                                                5.2.2.3 Adults

                                5.2.3 Cardiac Applications            

                                                5.2.3.1 Neonates

                                                5.2.3.2 Pediatrics

                                                5.2.3.3 Adults

                                5.2.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)        

                                                5.2.4.1 Neonates

                                                5.2.4.2 Pediatrics

                                                5.2.4.3 Adults

                                5.2.5 Y-o-Y Growth Analysis, By Application         

                                5.2.6 Market Attractiveness Analysis, By Application       

                                5.2.7 Market Share Analysis, By Application        

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Modality

                                                6.1.3.3 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Modality

                                                6.1.5.3 By Application

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Getinge Group                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Medtronic plc                            

                8.3 LivaNova PLC                             

                8.4 XENIOS AG                 

                8.5 Terumo Corporation                               

                8.6 MicroPort Scientific Corporation                       

                8.7 NIPRO Corporation                 

                8.8 OriGen Biomedical Inc.                          

                8.9 ALung Technologies Inc.                       

                8.10 EUROSETS S.r.l.                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Modality and Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Extracorporeal Membrane Oxygenation Machine  Market By Region, From 2016-2021 ( USD Million )
  2. Global Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  3. Global Veno-Arterial (VA) Market By Region, From 2016-2021 ( USD Million )
  4. Global Veno-Venous (VV) Market By Region, From 2016-2021 ( USD Million )
  5. Global Arterio-Venous (AV) Market By Region, From 2016-2021 ( USD Million )
  6. Global Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  7. Global Respiratory Market By Region, From 2016-2021 ( USD Million )
  8. Global Cardiac Market By Region, From 2016-2021 ( USD Million )
  9. Global Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2016-2021 ( USD Million )
  10. North America Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  11. North America Veno-Arterial (VA) Market By Region, From 2016-2021 ( USD Million )
  12. North America Veno-Venous (VV) Market By Region, From 2016-2021 ( USD Million )
  13. North America Arterio-Venous (AV) Market By Region, From 2016-2021 ( USD Million )
  14. North America Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  15. North America Respiratory Market By Region, From 2016-2021 ( USD Million )
  16. North America Cardiac Market By Region, From 2016-2021 ( USD Million )
  17. North America Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2016-2021 ( USD Million )
  18. United States Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  19. United States Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  20. Canada Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  21. Canada Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  22. Europe Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  23. Europe Veno-Arterial (VA) Market By Region, From 2016-2021 ( USD Million )
  24. Europe Veno-Venous (VV) Market By Region, From 2016-2021 ( USD Million )
  25. Europe Arterio-Venous (AV) Market By Region, From 2016-2021 ( USD Million )
  26. Europe Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  27. Europe Respiratory Market By Region, From 2016-2021 ( USD Million )
  28. Europe Cardiac Market By Region, From 2016-2021 ( USD Million )
  29. Europe Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2016-2021 ( USD Million )
  30. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  31. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  32. Germany Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  33. Germany Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  34. France Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  35. France Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  36. Italy Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  37. Italy Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  38. Spain Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  39. Spain Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  40. Asia-Pacific Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  41. Asia-Pacific Veno-Arterial (VA) Market By Region, From 2016-2021 ( USD Million )
  42. Asia-Pacific Veno-Venous (VV) Market By Region, From 2016-2021 ( USD Million )
  43. Asia-Pacific Arterio-Venous (AV) Market By Region, From 2016-2021 ( USD Million )
  44. Asia-Pacific Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  45. Asia-Pacific Respiratory Market By Region, From 2016-2021 ( USD Million )
  46. Asia-Pacific Cardiac Market By Region, From 2016-2021 ( USD Million )
  47. Asia-Pacific Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2016-2021 ( USD Million )
  48. Japan Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  49. Japan Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  50. China Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  51. China Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  52. India Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  53. India Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  54. Australia Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  55. Australia Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  56. South Korea Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  57. South Korea Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  58. Latin America Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  59. Latin America Veno-Arterial (VA) Market By Region, From 2016-2021 ( USD Million )
  60. Latin America Veno-Venous (VV) Market By Region, From 2016-2021 ( USD Million )
  61. Latin America Arterio-Venous (AV) Market By Region, From 2016-2021 ( USD Million )
  62. Latin America Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  63. Latin America Respiratory Market By Region, From 2016-2021 ( USD Million )
  64. Latin America Cardiac Market By Region, From 2016-2021 ( USD Million )
  65. Latin America Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2016-2021 ( USD Million )
  66. Brazil Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  67. Brazil Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  68. Argentina Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  69. Argentina Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  70. Mexico Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  71. Mexico Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  72. Rest of Latin America Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  73. Rest of Latin America Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  74. Middle East & Africa Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  75. Middle East & Africa Veno-Arterial (VA) Market By Region, From 2016-2021 ( USD Million )
  76. Middle East & Africa Veno-Venous (VV) Market By Region, From 2016-2021 ( USD Million )
  77. Middle East & Africa Arterio-Venous (AV) Market By Region, From 2016-2021 ( USD Million )
  78. Middle East & Africa Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  79. Middle East & Africa Respiratory Market By Region, From 2016-2021 ( USD Million )
  80. Middle East & Africa Cardiac Market By Region, From 2016-2021 ( USD Million )
  81. Middle East & Africa Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2016-2021 ( USD Million )
  82. Middle East Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  83. Middle East Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  84. Africa Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  85. Africa Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
Middle East And Africa Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends, And ...
Latin America Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts ...
Asia Pacific Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (...
Europe Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 ...
North America Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts ...
Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters) And Region - Global Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016 To...
Middle East And Africa Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Impla...
Latin America Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable He...
Middle East And Africa Hyperbaric Oxygen (HBO) Therapy Devices Market By Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism, Others), By Product (Monoplace HBOT Devices, Multiplace...
Asia Pacific Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hea...
Europe Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing D...
Latin America Hyperbaric Oxygen (HBO) Therapy Devices Market By Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism, Others), By Product (Monoplace HBOT Devices, Multiplace HBOT Dev...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.